ZA959221B - Cisapride extended release - Google Patents

Cisapride extended release

Info

Publication number
ZA959221B
ZA959221B ZA959221A ZA959221A ZA959221B ZA 959221 B ZA959221 B ZA 959221B ZA 959221 A ZA959221 A ZA 959221A ZA 959221 A ZA959221 A ZA 959221A ZA 959221 B ZA959221 B ZA 959221B
Authority
ZA
South Africa
Prior art keywords
cisapride
extended release
extended
release
cisapride extended
Prior art date
Application number
ZA959221A
Other languages
English (en)
Inventor
Eugene Maria Jozef Jans
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA959221B publication Critical patent/ZA959221B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cereal-Derived Products (AREA)
ZA959221A 1994-11-02 1995-10-13 Cisapride extended release ZA959221B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94203184 1994-11-02

Publications (1)

Publication Number Publication Date
ZA959221B true ZA959221B (en) 1997-04-30

Family

ID=8217338

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959221A ZA959221B (en) 1994-11-02 1995-10-13 Cisapride extended release

Country Status (29)

Country Link
US (2) US6153623A (ko)
EP (1) EP0789572A1 (ko)
JP (1) JP3182423B2 (ko)
KR (1) KR100255521B1 (ko)
AP (1) AP658A (ko)
AR (1) AR001765A1 (ko)
AU (1) AU704284B2 (ko)
BG (1) BG63244B1 (ko)
BR (1) BR9509565A (ko)
CA (1) CA2203663C (ko)
CZ (1) CZ287844B6 (ko)
EE (1) EE03510B1 (ko)
FI (1) FI971856A0 (ko)
HR (1) HRP950539A2 (ko)
HU (1) HUT77887A (ko)
IL (1) IL115843A0 (ko)
MY (1) MY113092A (ko)
NO (1) NO312538B1 (ko)
NZ (1) NZ295166A (ko)
OA (1) OA10419A (ko)
PL (1) PL181470B1 (ko)
RO (1) RO116042B1 (ko)
RU (1) RU2143890C1 (ko)
SK (1) SK54297A3 (ko)
TR (1) TR199501351A2 (ko)
TW (1) TW466114B (ko)
UA (1) UA50721C2 (ko)
WO (1) WO1996014070A1 (ko)
ZA (1) ZA959221B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
CA2232489A1 (en) * 1995-12-01 1997-06-12 Janssen Pharmaceutica N.V. Cisapride sustained release
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
JP2001507359A (ja) * 1997-01-03 2001-06-05 エラン コーポレーション ピーエルシー 徐放性シサプリドミニ錠剤製剤
JP2002504107A (ja) * 1997-06-11 2002-02-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ (+)−または(−)−シサプリドの即時放出性pH非依存的固形投薬剤形
TW407058B (en) 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
KR100660594B1 (ko) * 1999-03-31 2006-12-22 얀센 파마슈티카 엔.브이. 방출 조절형 제제중의 프리젤라틴화 전분
EP1060743A1 (en) * 1999-06-17 2000-12-20 Development Center For Biotechnology Oral cisapride dosage forms with an extended duration
DZ3473A1 (fr) 2000-09-29 2002-04-04 Solvay Pharm Bv Formulation pharmaceutique a liberation prolongee independante de la force ionique.
ATE408400T1 (de) * 2002-05-21 2008-10-15 Watson Lab Inc Pharmazeutische zusammensetzung mit verzögerter freisetzung
KR101082774B1 (ko) 2006-04-12 2011-11-11 닛뽕소다 가부시키가이샤 서방성 정제의 제조 방법
RU2356532C2 (ru) * 2007-06-01 2009-05-27 Открытое Акционерное Общество "Отечественные Лекарства" Фармацевтическая композиция проксодолола с контролируемым высвобождением
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
WO1993018755A1 (en) * 1992-03-25 1993-09-30 Depomed Systems, Incorporated Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
JPH08502032A (ja) * 1992-07-07 1996-03-05 セプラコア インコーポレーテッド 胃食道逆流疾患およびその他の障害を治療するために▲(−)▼シサプリドを使用する方法
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
FI971856A (fi) 1997-04-30
NZ295166A (en) 1999-03-29
KR100255521B1 (ko) 2000-05-01
EE9700105A (et) 1997-12-15
AP658A (en) 1998-08-17
JPH09511760A (ja) 1997-11-25
AP9700969A0 (en) 1997-04-30
OA10419A (en) 2001-12-06
HRP950539A2 (en) 1997-08-31
CA2203663A1 (en) 1996-05-17
US6274599B1 (en) 2001-08-14
AR001765A1 (es) 1997-12-10
AU3844795A (en) 1996-05-31
FI971856A0 (fi) 1997-04-30
HUT77887A (hu) 1998-09-28
MY113092A (en) 2001-11-30
RU2143890C1 (ru) 2000-01-10
AU704284B2 (en) 1999-04-15
CZ124497A3 (en) 1997-08-13
CZ287844B6 (en) 2001-02-14
JP3182423B2 (ja) 2001-07-03
PL181470B1 (pl) 2001-07-31
WO1996014070A1 (en) 1996-05-17
EE03510B1 (et) 2001-10-15
CA2203663C (en) 2002-04-30
IL115843A0 (en) 1996-01-31
UA50721C2 (uk) 2002-11-15
BR9509565A (pt) 1997-09-16
US6153623A (en) 2000-11-28
PL319948A1 (en) 1997-09-01
MX9703249A (es) 1997-07-31
BG101401A (en) 1997-12-30
TW466114B (en) 2001-12-01
NO971832D0 (no) 1997-04-21
TR199501351A2 (tr) 1996-06-21
EP0789572A1 (en) 1997-08-20
SK54297A3 (en) 1997-10-08
RO116042B1 (ro) 2000-10-30
BG63244B1 (bg) 2001-07-31
NO971832L (no) 1997-04-21
NO312538B1 (no) 2002-05-27

Similar Documents

Publication Publication Date Title
DE59704951D1 (en) Plättchenförmiges titandioxidpigment
ZA97171B (en) Novel use
TW407503U (en) Syrings
DE59705192D1 (en) Lcp-blends
DE59700372D1 (en) Blockcopolymere
GB9413957D0 (en) Release devices
ZA959221B (en) Cisapride extended release
DE59704086D1 (en) Twin-dualmode-filter
DE59703905D1 (en) Linearmotorgetriebene transportanlage
GB9606016D0 (en) Novel use
DE59703023D1 (en) Cyclopeptidderivate
DE59702027D1 (en) Bragg-modulator
GB9621990D0 (en) Use
GB9626243D0 (en) Safe re-locker
GB9915929D0 (en) Novel release latch-c-i-p
DE59705556D1 (en) Peripheralpumpe
SK5595A3 (en) Built-in mechanizm
AU131132S (en) Handleset
GB9611192D0 (en) Use
GB9506864D0 (en) Release device
AU131198S (en) Handleset
DE59610178D1 (en) Rotationspumpe
AU131199S (en) Handleset
AU131131S (en) Handleset
GB2317576B (en) Cycles